FDA approves AstraZeneca, Sanofi shot that protects infants and toddlers against RSV

Photo caption: Blood sample for respiratory syncytial virus (RSV) test. Photo credit: Jarun011 | Istock | Getty Images. Article by Spencer Kimball. CNBC – July 17, 2023.

The Food and Drug Administration on Monday approved AstraZeneca and Sanofi’s shot that protects infants and toddlers against respiratory syncytial virus, which is the leading cause of hospitalization among babies in the U.S. Nirsevimab is the first shot approved by the FDA to protect all infants against RSV regardless of whether they are healthy or have a medical condition. […]

Click here to view original web page at www.cnbc.com